FI944022A - Estrogeeni/progestiini/antiprogestiinimenetelmä ja -pakkaus oraaliseen hedelmöityksen ehkäisyyn sekä kuukautisten säätelemiseksi - Google Patents

Estrogeeni/progestiini/antiprogestiinimenetelmä ja -pakkaus oraaliseen hedelmöityksen ehkäisyyn sekä kuukautisten säätelemiseksi Download PDF

Info

Publication number
FI944022A
FI944022A FI944022A FI944022A FI944022A FI 944022 A FI944022 A FI 944022A FI 944022 A FI944022 A FI 944022A FI 944022 A FI944022 A FI 944022A FI 944022 A FI944022 A FI 944022A
Authority
FI
Finland
Prior art keywords
antiprogestin
progestin
menstruation
estrogen
packaging
Prior art date
Application number
FI944022A
Other languages
English (en)
Swedish (sv)
Other versions
FI944022A0 (fi
FI110307B (fi
Inventor
Gary D Hodgen
Krzysztof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI944022A0 publication Critical patent/FI944022A0/fi
Publication of FI944022A publication Critical patent/FI944022A/fi
Application granted granted Critical
Publication of FI110307B publication Critical patent/FI110307B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI944022A 1992-03-02 1994-09-01 Estrogeeni/progestiini/antiprogestiinia sisältävä ehkäisyvalmiste ja pakkaus FI110307B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US84305892A 1992-03-02 1992-03-02
US84305892 1992-03-02
US9301931 1993-03-02
CN93102182 1993-03-02
CN93102182A CN1090481C (zh) 1992-03-02 1993-03-02 雌激素/孕激素/抗孕激素的应用,其组合物和药盒
PCT/US1993/001931 WO1993017686A1 (en) 1992-03-02 1993-03-02 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses

Publications (3)

Publication Number Publication Date
FI944022A0 FI944022A0 (fi) 1994-09-01
FI944022A true FI944022A (fi) 1994-09-01
FI110307B FI110307B (fi) 2002-12-31

Family

ID=25743002

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944022A FI110307B (fi) 1992-03-02 1994-09-01 Estrogeeni/progestiini/antiprogestiinia sisältävä ehkäisyvalmiste ja pakkaus

Country Status (16)

Country Link
US (1) US7538099B1 (fi)
EP (1) EP0630246B1 (fi)
JP (1) JP4152431B2 (fi)
CN (1) CN1090481C (fi)
AU (1) AU678150B2 (fi)
BR (1) BR9306005A (fi)
CZ (1) CZ291988B6 (fi)
FI (1) FI110307B (fi)
IL (1) IL104915A (fi)
MX (1) MX9301121A (fi)
NO (1) NO311327B1 (fi)
NZ (1) NZ268304A (fi)
PL (2) PL174785B1 (fi)
SK (1) SK285963B6 (fi)
WO (1) WO1993017686A1 (fi)
ZA (1) ZA931492B (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19531936A1 (de) * 1995-08-17 1997-02-20 Schering Ag Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
CN1281363A (zh) 1997-11-14 2001-01-24 阿克佐诺贝尔公司 孕激素-抗孕激素体系
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
HUP0201875A3 (en) * 1999-04-29 2003-10-28 Akzo Nobel Nv Use of antiprogestagens for preparing pharmaceutical compositions for contraception in combined therapy
EP1605924B1 (en) 1999-08-31 2008-11-05 Bayer Schering Pharma Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
EP2305230B1 (en) 2001-12-05 2015-11-04 Teva Women's Health, Inc. Oral contraceptives to prevent pregnancy
US7772219B2 (en) 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
BRPI0412493A (pt) * 2003-07-16 2006-10-17 Duramed Pharmaceuticals Inc métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
EP2868323A1 (en) 2013-11-03 2015-05-06 Flamina Holding AG A pharmaceutical composition or group of compositions for inhibiting autocrine HCG production in adult human cells
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10098894B2 (en) 2014-07-29 2018-10-16 Therapeuticsmd, Inc. Transdermal cream
KR20170084086A (ko) 2014-11-17 2017-07-19 아르노 테라퓨틱스 인코포레이티드 오나프리스톤 연장-방출 조성물 및 방법
CN107995864A (zh) * 2015-05-18 2018-05-04 敏捷治疗公司 避孕组合物及提高效能和调节副作用的方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
JP2018528944A (ja) 2015-09-25 2018-10-04 コンテクスト バイオファーマ インコーポレイテッド オナプリストン中間体の製造方法
KR20180113988A (ko) 2015-12-15 2018-10-17 컨텍스트 바이오파마 인코포레이티드 비정질 오나프리스톤 조성물 및 그 제조방법
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3890356A (en) 1973-03-26 1975-06-17 Richardson Merrell Inc 7-Alkyl-{66 {hu 3,5{b -steroids
US3928398A (en) 1973-11-01 1975-12-23 Richardson Merrell Inc Derivatives of 7{60 -methylestr-4-en-3{60 ,17{62 -diol
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
US4416822A (en) 1982-07-09 1983-11-22 The Upjohn Company 17β-Difluoromethyl steroids
IL68222A (en) 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
ES8502612A1 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
DE3702383A1 (de) 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
US5116818A (en) 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
US5108995A (en) 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
MX9301121A (es) 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5622943A (en) 1992-05-06 1997-04-22 The Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
WO1993021926A1 (en) 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
US5468736A (en) 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy
DE4344463A1 (de) 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption

Also Published As

Publication number Publication date
NO943234L (no) 1994-11-01
MX9301121A (es) 1993-09-01
FI944022A0 (fi) 1994-09-01
AU678150B2 (en) 1997-05-22
PL172790B1 (pl) 1997-11-28
JPH07509218A (ja) 1995-10-12
CZ211194A3 (en) 1995-12-13
BR9306005A (pt) 1998-06-23
NZ268304A (en) 1997-02-24
SK104694A3 (en) 1996-01-10
EP0630246B1 (en) 2008-07-16
NO943234D0 (no) 1994-09-01
AU3787993A (en) 1993-10-05
EP0630246A1 (en) 1994-12-28
CZ291988B6 (cs) 2003-07-16
US7538099B1 (en) 2009-05-26
FI110307B (fi) 2002-12-31
PL174785B1 (pl) 1998-09-30
JP4152431B2 (ja) 2008-09-17
SK285963B6 (sk) 2007-12-06
WO1993017686A1 (en) 1993-09-16
ZA931492B (en) 1993-12-23
IL104915A0 (en) 1993-07-08
IL104915A (en) 1998-07-15
NO311327B1 (no) 2001-11-19
CN1090481C (zh) 2002-09-11
EP0630246A4 (en) 2002-07-17
CN1079386A (zh) 1993-12-15

Similar Documents

Publication Publication Date Title
FI944022A (fi) Estrogeeni/progestiini/antiprogestiinimenetelmä ja -pakkaus oraaliseen hedelmöityksen ehkäisyyn sekä kuukautisten säätelemiseksi
FI845065A0 (fi) Maongsammansatt kombinationspreparat foer oralt bruk foer foerhindrande av graviditet.
ZA933133B (en) Application for introducing a cream-type substance into a woman's vagina
IL115399A0 (en) A pharmaceutical composition comprising a combination of prostacyclin with an estrogen or progestin
GB2104779B (en) Method of contraception and pharmaceutical package therefor
HUT75033A (en) Non-solvated crystalline form of raloxifene and pharmaceutical containing the same
NO942937D0 (no) Innretning for korreksjon av mindre inkontinens hos kvinner
AU5659194A (en) Preventive device for contraception and infection
AP9300542A0 (en) 17a and 17b-alkylketone-3-carboxyaromatic a ring steroidal compounds and pharmaceutical compositions containing these compounds
FI20021041A (fi) Estrogeeni/progestiini/antiprogestiinimenetelmä kuukautisten säätelemiseksi
FI943729A0 (fi) Kohdunsisäisen hedelmöitymistä ehkäisevän laitteen ja asetinvälineen yhdistelmä
GB9410058D0 (en) Film construction for a disposable ostomy pouch and method of making same
GB9615121D0 (en) Metyhod of and means for contraception
AU119045S (en) A set of packaged tampons
FI952713A0 (fi) Hedelmöitystä ehkäisevän, kohtua varten olevan laitteen ja vastaavan sisäänvientivälineen yhdistelmä
ZA938054B (en) A method of promoting wound healing and compositions useful for same
RU1769713C (en) Method and device for fabrication of hygienic tampons
RO102334B1 (en) Device for plying and forming packages of polyethylene bags
SE9300972D0 (sv) Anordning foer foerskjutbar uppbaerning av en laada eller liknande
SE9203856D0 (sv) Anordning foer foerskjutbar uppbaerning av en laada eller liknande
SE9003751D0 (sv) Saett och anordning foer modulbaserad emballering av laangstraeckta foeremaal
GB9202430D0 (en) Disposal container air tight for condoms and for sanitary towels etc
GB9216770D0 (en) (2h-pyrrol-2-ylidene)methyl derivatives and process for their preparation
HU1239U (en) Device for tearing of root
SE9203093D0 (sv) Foerfarande och anordning foer laeggning av ett tak uppvisande vaagformiga plattor

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: EASTERN VIRGINIA MEDICAL SCHOOL

Free format text: EASTERN VIRGINIA MEDICAL SCHOOL